Atlas Trials

Shanghai Cancer Hospital, China

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shanghai Cancer Hospital, China

RecordFirmDate
A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatment of Refractory Non-squamous Non-small Cell Lung Cancer with Leptomeningeal Metastases (NCT06901817)Shanghai Cancer Hospital, China2025-03-01
Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer (NCT05800223)Shanghai Cancer Hospital, China2023-01-01
Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs (NCT04519983)Shanghai Cancer Hospital, China2022-01-01
Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors (NCT04517539)Shanghai Cancer Hospital, China2020-12-01
Efficacy and Safety of Platinum-based Chemotherapy + Bevacizumab + Durvalumab, and Salvage SBRT for IV Non-Small Cell Lung Cancer Patients With EGFR Mutations After Failure of First Line Osimertinib: A Multicenter, Prospective, Phase II Clinical Study (NCT04517526)Shanghai Cancer Hospital, China2020-11-01
Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study (NCT04513301)Shanghai Cancer Hospital, China2020-01-01

Track Shanghai Cancer Hospital, China automatically

Every clearance here is in the API, with alerts when new ones post.